Developmental changes in threshold, conduction velocity, and depressive action of lignocaine on dorsal root potentials from neonatal rats are associated with maturation of myelination.
Conduction velocity of primary afferent fibres and blocking actions of local anaesthetics seem to be developmentally regulated. The current work investigated physiological (threshold, conduction velocity, and myelination) and pharmacological (lignocaine (0.0625 to 2 mmol/L) and capsaicin (2 micromol/L)) ontogenic changes on in vitro sciatic nerve-dorsal root preparations from 0- to 12-day-old rats. As rats aged, stimulus intensities necessary to evoke A-fibre thresholds significantly decreased and A-fibre conduction velocities significantly increased. For C-fibres, thresholds significantly increased and conduction velocities significantly varied with age. The blocking potency of lignocaine varied with age: A-fibres from 4-day-old rats and younger were significantly more resistant than those from older rats, and C-fibres were blocked more uniformly amongst ages. Capsaicin significantly depressed C-fibres irrespective of age, and A-fibres were significantly reduced during the first postnatal week only. Myelination significantly increased as rats aged. A-fibre physiological parameters were significantly correlated with both other A-fibre physiological and pharmacological parameters, but C-fibre parameters were not. Peripheral A-fibre transduction mechanisms seem to require time to acquire their full stimulus-response sensitivity, which coincides with development of myelination. In contrast, peripheral C-fibres seem to have mature transduction mechanisms from the first days of postnatal life.
Lizarraga
I
I
IVABS, Massey University, Private Bag 11222, Palmerston North, New Zealand. madrigal@servidor.unam.mx
Chambers
J P
JP
Johnson
C B
CB
D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D002211:Capsaicin / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D008012:Lidocaine / Q000494:pharmacology*; D008297:Male; D009186:Myelin Sheath / Q000502:physiology*; D009413:Nerve Fibers, Myelinated / Q000502:physiology; D009431:Neural Conduction / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013126:Spinal Nerve Roots / Q000187:drug effects* / Q000502:physiology
D000779:Anesthetics, Local; D000431:Ethanol; D008012:Lidocaine; D002211:Capsaicin